# Via Transportation, Inc.: financial statements, quarterly

VIA · NYSE · CIK 1603015 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/via.md) · [Financials](/companies/via/financials.md) · [Filings](/companies/via/filings.md) · [Insiders](/companies/via/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/via/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [83.3](/filings/0001603015-25-000042.md) | [91.7 d](/filings/0001603015-26-000008.md) | [98.6](/filings/0001603015-26-000014.md) | [107](/filings/0001603015-26-000026.md) | [110](/filings/0001603015-25-000042.md) | [119 d](/filings/0001603015-26-000008.md) | [127](/filings/0001603015-26-000014.md) | [136](/filings/0001603015-26-000026.md) |
| Cost of revenue | $m | [51.3](/filings/0001603015-25-000042.md) | [54.7 d](/filings/0001603015-26-000008.md) | [58.8](/filings/0001603015-26-000014.md) | [65.2](/filings/0001603015-26-000026.md) | [66.6](/filings/0001603015-25-000042.md) | [72.0 d](/filings/0001603015-26-000008.md) | [77.4](/filings/0001603015-26-000014.md) | [80.1](/filings/0001603015-26-000026.md) |
| Gross profit | $m | [32.0](/filings/0001603015-25-000042.md) | [37.0 d](/filings/0001603015-26-000008.md) | [39.8](/filings/0001603015-26-000014.md) | [42.0](/filings/0001603015-26-000026.md) | [43.1](/filings/0001603015-25-000042.md) | [47.0 d](/filings/0001603015-26-000008.md) | [50.1](/filings/0001603015-26-000014.md) | [55.6](/filings/0001603015-26-000026.md) |
| Research and development | $m | [22.2](/filings/0001603015-25-000042.md) | [21.4 d](/filings/0001603015-26-000008.md) | [21.3](/filings/0001603015-26-000014.md) | [22.7](/filings/0001603015-26-000026.md) | [23.1](/filings/0001603015-25-000042.md) | [25.1 d](/filings/0001603015-26-000008.md) | [24.5](/filings/0001603015-26-000014.md) | [26.1](/filings/0001603015-26-000026.md) |
| Operating income | $m | [(20.7)](/filings/0001603015-25-000042.md) | [(16.9) d](/filings/0001603015-26-000008.md) | [(17.2)](/filings/0001603015-26-000014.md) | [(16.1)](/filings/0001603015-26-000026.md) | [(18.9)](/filings/0001603015-25-000042.md) | [(24.4) d](/filings/0001603015-26-000008.md) | [(23.6)](/filings/0001603015-26-000014.md) | [(21.8)](/filings/0001603015-26-000026.md) |
| Interest expense | $m | [0.9](/filings/0001603015-25-000042.md) | [1.9 d](/filings/0001603015-26-000008.md) | [2.4](/filings/0001603015-26-000014.md) | [2.4](/filings/0001603015-26-000026.md) | [2.1](/filings/0001603015-25-000042.md) | [0.4 d](/filings/0001603015-26-000008.md) | [0.2](/filings/0001603015-26-000014.md) | [0.3](/filings/0001603015-26-000026.md) |
| Income tax | $m | [0.4](/filings/0001603015-25-000042.md) | [0.3 d](/filings/0001603015-26-000008.md) | [0.8](/filings/0001603015-26-000014.md) | [0.9](/filings/0001603015-26-000026.md) | [0.5](/filings/0001603015-25-000042.md) | [0.4 d](/filings/0001603015-26-000008.md) | [0.6](/filings/0001603015-26-000014.md) | [0.2](/filings/0001603015-26-000026.md) |
| Net income | $m | [(21.3)](/filings/0001603015-25-000042.md) | [(18.8) d](/filings/0001603015-26-000008.md) | [(16.3)](/filings/0001603015-26-000014.md) | [(21.2)](/filings/0001603015-26-000026.md) | [(36.9)](/filings/0001603015-25-000042.md) | [(21.9) d](/filings/0001603015-26-000008.md) | [(20.1)](/filings/0001603015-26-000014.md) | [(19.6)](/filings/0001603015-26-000026.md) |
| Diluted EPS | $ per share | [(1.70)](/filings/0001603015-25-000042.md) | not reported | [(1.28)](/filings/0001603015-26-000014.md) | [(1.65)](/filings/0001603015-26-000026.md) | [(1.49)](/filings/0001603015-25-000042.md) | not reported | [(0.25)](/filings/0001603015-26-000014.md) | [(0.24)](/filings/0001603015-26-000026.md) |
| Basic EPS | $ per share | [(1.70)](/filings/0001603015-25-000042.md) | not reported | [(1.28)](/filings/0001603015-26-000014.md) | [(1.65)](/filings/0001603015-26-000026.md) | [(1.49)](/filings/0001603015-25-000042.md) | not reported | [(0.25)](/filings/0001603015-26-000014.md) | [(0.24)](/filings/0001603015-26-000026.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-01-01) | period not labelled (2023-12-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [77.9](/filings/0001603015-26-000008.md) | not reported | not reported | [378](/filings/0001603015-25-000042.md) | [371](/filings/0001603015-26-000026.md) | [348](/filings/0001603015-26-000014.md) | [336](/filings/0001603015-26-000026.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [163](/filings/0001603015-26-000008.md) | not reported | not reported | [479](/filings/0001603015-25-000042.md) | [470](/filings/0001603015-26-000026.md) | [461](/filings/0001603015-26-000014.md) | [458](/filings/0001603015-26-000026.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [379](/filings/0001603015-26-000008.md) | not reported | not reported | [702](/filings/0001603015-25-000042.md) | [733](/filings/0001603015-26-000026.md) | [723](/filings/0001603015-26-000014.md) | [718](/filings/0001603015-26-000026.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [76.5](/filings/0001603015-26-000008.md) | not reported | not reported | [92.7](/filings/0001603015-25-000042.md) | [94.2](/filings/0001603015-26-000026.md) | [90.6](/filings/0001603015-26-000014.md) | [90.8](/filings/0001603015-26-000026.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [172](/filings/0001603015-26-000008.md) | not reported | not reported | [127](/filings/0001603015-25-000042.md) | [105](/filings/0001603015-26-000026.md) | [101](/filings/0001603015-26-000014.md) | [100](/filings/0001603015-26-000026.md) |
| Shareholders' equity | $m | [(825)](/filings/0001603015-26-000008.md) | [(919)](/filings/0001603015-26-000008.md) | [(958)](/filings/0001603015-25-000042.md) | [(969)](/filings/0001603015-25-000042.md) | [(987)](/filings/0001603015-26-000008.md) | [(995)](/filings/0001603015-26-000026.md) | [(1,004)](/filings/0001603015-26-000026.md) | [575](/filings/0001603015-25-000042.md) | [628](/filings/0001603015-26-000026.md) | [622](/filings/0001603015-26-000014.md) | [618](/filings/0001603015-26-000026.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(17.7) d](/filings/0001603015-26-000008.md) | [(5.6)](/filings/0001603015-26-000014.md) | [(16.3) d](/filings/0001603015-26-000026.md) | [(8.5) d](/filings/0001603015-25-000042.md) | [(0.5) d](/filings/0001603015-26-000008.md) | [(21.2)](/filings/0001603015-26-000014.md) | [(10.6) d](/filings/0001603015-26-000026.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001603015-26-000008.md) | [0.4](/filings/0001603015-26-000014.md) | [0.6 d](/filings/0001603015-26-000026.md) | [0.4 d](/filings/0001603015-25-000042.md) | [0.3 d](/filings/0001603015-26-000008.md) | [0.3](/filings/0001603015-26-000014.md) | [0.4 d](/filings/0001603015-26-000026.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.5](/filings/0001603015-25-000042.md) | [12.8](/filings/0001603015-26-000014.md) | [12.8](/filings/0001603015-26-000026.md) | [24.7](/filings/0001603015-25-000042.md) | [81.2](/filings/0001603015-26-000014.md) | [81.3](/filings/0001603015-26-000026.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.